-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Systemic lupus erythematosus (SLE) is a systemic self- immune inflammatory disease, and premature atherosclerosis of arteries and heart blood vessels increased risk
Immune heart blood vessels
Recently, a research article was published in JAHA, an authoritative journal in the field of cardiovascular diseases.
The study included consecutive SLE patients (n=42) who underwent cardiac positron emission tomography-computed tomography, and excluded patients with obstructive coronary artery disease and systolic dysfunction
MFR and burden of atherosclerosis in SLE patients
Although the burden of non-obstructive atherosclerosis was similar, compared with the control group, the overall MFR of SLE patients decreased significantly, and the prevalence of CMD was higher (1.
It can be seen that the prevalence of coronary vasomotor abnormalities in SLE patients with cardiac symptoms without obstructive coronary artery disease is high
SLE patients with cardiac symptoms without obstructive coronary artery disease have a high prevalence of coronary vasomotor abnormalities
Original source:
Brittany N.